Interview for M.Pharm, MSc as Trainee at Biophore
26 June 2025

Interview for M.Pharm, MSc as Trainee at Biophore

Conduct Experiments and Write Laboratory Notebooks Good Academic knowledge and Communication skills
Eli Lilly Launches Mounjaro KwikPen in India to Rival Novo Nordisk Wegovy
26 June 2025
Eli Lilly Launches Mounjaro KwikPen in India to Rival Novo Nordisk Wegovy
As reported by Reuters, U.S. pharmaceutical giant Eli Lilly has launched its Mounjaro KwikPen in India, expanding its portfolio of treatments for diabetes and obesity.
Lupin Launches Generic Prucalopride Tablets in U.S. for Chronic Constipation Treatment
26 June 2025
Lupin Launches Generic Prucalopride Tablets in U.S. for Chronic Constipation Treatment

Lupin Limited, a leading global pharmaceutical company, has announced the launch of its Prucalopride Tablets in 1 mg and 2 mg strengths in the United States, following the recent approval of its Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA). 

Sanofi’s Riliprubart earns USFDA orphan drug designation for organ transplant complication
26 June 2025
Sanofi’s Riliprubart earns USFDA orphan drug designation for organ transplant complication
In a promising development for transplant medicine, global healthcare leader Sanofi has announced that its investigational therapy riliprubart has received Orphan Drug Designation from the U.S. Food and Drug Administration.
UCSD develops gene therapy that preserves memory in Alzheimer’s mouse models
26 June 2025
UCSD develops gene therapy that preserves memory in Alzheimer’s mouse models
A pioneering gene therapy engineered by researchers at the University of California San Diego (UCSD) School of Medicine demonstrates remarkable promise in halting, and potentially reversing, cognitive decline in preclinical Alzheimer’s models.
Glenmark Pharmaceuticals launches TEVIMBRA® in India, boosting access to advanced Immuno-Oncology treatments
26 June 2025
Glenmark Pharmaceuticals launches TEVIMBRA® in India, boosting access to advanced Immuno-Oncology treatments
Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its official entry into the immuno-oncology segment.
A Game-Changing Wireless Implant for Personalized Chronic Pain Relief
26 June 2025
A Game-Changing Wireless Implant for Personalized Chronic Pain Relief
Chronic pain is a debilitating condition that severely impacts quality of life, often leading to reliance on opioid medications with their severe side effects and addiction risks.
Openings for D.Pharm, B.Pharm at DPSRU - 06 Openings
25 June 2025
Openings for D.Pharm, B.Pharm at DPSRU - 06 Openings
Bachelors degree in pharmacy with 02 years experience in level 02. OR Diploma in pharmacy with 04 years experience in level 02.
Pharma Faculty Recruitment at Vinayaka Group of Colleges
25 June 2025
Pharma Faculty Recruitment at Vinayaka Group of Colleges
PHARMACEUTICS, PHARMACEUTICAL CHEMISTRY, PHARMACOLOGY, PHARMACOGNOSY, PHARMACY PRACTICE
NBRC invites application for Research Associate Post
25 June 2025
NBRC invites application for Research Associate Post
Demonstrable experience in Neuroscience or RNA Biochemistry in the form of publication. Experience in animal handling, viral injections in brain and animal behaviour or sequencing data analysis.